亚太地区直接面向消费者的基因检测市场预测至 2030 年 - 区域分析 - 按检测类型、技术和配销通路
市场调查报告书
商品编码
1463716

亚太地区直接面向消费者的基因检测市场预测至 2030 年 - 区域分析 - 按检测类型、技术和配销通路

Asia Pacific Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel

出版日期: | 出版商: The Insight Partners | 英文 78 Pages | 订单完成后即时交付

价格

2022年亚太地区直接面向消费者的基因检测市场价值为3.5424亿美元,预计到2030年将达到15.3084亿美元;预计2022年至2030年CAGR为20.1%。

单核苷酸多态性 (SNP) 晶片的日益普及推动了亚太地区直接面向消费者的基因检测市场

近年来,随着科学知识的增加,从传统医学向个人化医学的典范稳步转变。这种转变归功于基因工程、单核苷酸多态性 (SNP) 基因分型以及微阵列和生物晶片技术的广泛采用。具有数十万个 SNP 的基因微阵列分析平台的引入将鼓励先进演算法的实施,以更公开地测试个体之间更隐蔽的家谱关係。此外,检测恶性肿瘤的需求也有所增加。在儿科领域,由于无需将 SNP 变异与大规模缺失杂交,週转时间短,因此产生了巨大的需求。因此,随着更多基因异常的检测和治疗,市场预计将会成长。

由于对技术先进和更复杂的 DTC 基因检测的持续需求,高效、准确的 SNP 晶片的需求不断增加。人们对 SNP 晶片的高度偏好可归因于它们能够测量剂量变化和 DNA 多态性,以及对癌症研究至关重要的各种应用,例如 SNP 微阵列分析。此外,对尽量减少 DTC 基因检测错误的需求日益增长,预计将推动 SNP 技术的采用,为市场成长提供机会。

亚太地区直接面向消费者的基因检测市场概况

亚太地区直接面向消费者的基因检测市场细分为中国、日本、印度、澳洲、韩国和亚太其他地区。预计在预测期内,该地区的市场将以全球所有主要地区中最快的速度成长。亚太地区直接面向消费者的基因检测市场的激增归因于对优质治疗解决方案的需求不断增加、对遗传性疾病早期筛检意识的提高以及对研发活动的日益关注。此外,基因组学研发的激增、大量患者以及医疗基础设施的升级预计将有利于预测期内亚太地区直接面向消费者的基因检测市场的成长。

亚太地区直接面向消费者的基因检测市场收入及 2030 年预测(百万美元)

亚太地区直接面向消费者的基因检测市场区隔

亚太地区直接面向消费者的基因测试市场分为测试类型、技术、配销通路和国家。

根据测试类型,亚太地区直接面向消费者的基因测试市场分为血统测试、预测测试、营养基因组学测试、带因者测试等。 2022 年,血统测验细分市场占据最大份额。

从技术面来看,亚太直接面向消费者的基因检测市场分为全基因组定序、单核苷酸多态性晶片、标靶分析等。 2022年,单核苷酸多态性晶片领域占据最大份额。

根据配销通路,亚太地区直接面向消费者的基因检测市场分为线上和线下。 2022 年,线上细分市场占据了更大的份额。

依国家/地区划分,亚太地区直接面向消费者的基因检测市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022年,中国在亚太地区直接面向消费者的基因检测市场占据主导地位。

Genesis Healthcare Co、Ancestry Genomics Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是亚太地区直接面向消费者的基因检测市场的一些领先公司。

目录

表中的内容

第 1 章:简介

第 2 章:执行摘要

  • 重要见解

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:亚太地区直接面向消费者的基因检测市场格局

  • 概述

第 5 章:亚太地区直接面向消费者的基因检测市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病的发生率不断上升
    • 提高对基因检测潜在益处的认识
  • 市场限制
    • 与直接面向消费者的基因检测相关的高成本和隐私问题
  • 市场机会
    • 单核苷酸多态性 (SNP) 晶片的采用日益广泛
  • 未来的趋势
    • 人们对药物基因学的兴趣日益浓厚,远距医疗的采用也不断增加
  • 影响分析

第 6 章:直接面向消费者的基因检测市场 - 亚太市场分析

  • 概述
  • 亚太地区直接面向消费者的基因检测市场收入,2022 - 2030

第 7 章:亚太地区直接面向消费者的基因测试市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年亚太地区直接面向消费者的基因测试市场收入份额(按测试类型划分)
  • 血统测试
  • 营养基因组学测试
  • 预测测试
  • 运营商测试
  • 其他的

第 8 章:亚太地区直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年亚太地区直接面向消费者的基因检测市场收入份额(按技术划分)
  • 全基因组定序
  • 单核苷酸多态性晶片
  • 针对性分析
  • 其他的

第 9 章:亚太地区直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年亚太地区直接面向消费者的基因检测市场收入份额(按配销通路划分)(%)
  • 线上平台
  • 线下平台

第 10 章:亚太地区直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 余下的

第 11 章:亚太地区直接面向消费者的基因检测市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章:公司简介

  • Genesis Healthcare Co
  • Ancestry Genomics Inc
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 23andMe Inc
  • Genetic Technologies Ltd

第 13 章:附录

Product Code: BMIRE00029624

The Asia Pacific direct-to-consumer genetic testing market was valued at US$ 354.24 million in 2022 and is expected to reach US$ 1,530.84 million by 2030; it is estimated to grow at a CAGR of 20.1% from 2022 to 2030.

Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the Asia Pacific Direct-to-Consumer Genetic Testing Market

There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.

SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.

Asia Pacific Direct-to-Consumer Genetic Testing Market Overview

The Asia Pacific direct-to-consumer genetic testing market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the fastest pace among all major regions in the world during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.

Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation

The Asia Pacific direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the Asia Pacific direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the Asia Pacific direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the Asia Pacific direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the Asia Pacific direct-to-consumer genetic testing market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific direct-to-consumer genetic testing market in 2022.

Genesis Healthcare Co, Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Asia Pacific direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. Asia Pacific Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - Asia Pacific Market Analysis

  • 6.1 Overview
  • 6.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
    • 10.1.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.7 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.8 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.8.1 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.8.2 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.8.3 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.9 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.10 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.10.1 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.10.2 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.10.3 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.11 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.12 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.12.1 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.12.2 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.12.3 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Asia Pacific Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Genesis Healthcare Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Ancestry Genomics Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Myriad Genetics, Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Living DNA Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 23andMe Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Genetic Technologies Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Asia Pacific Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. Asia Pacific Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. Asia Pacific Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 21. China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)